Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation

Br J Anaesth. 2014 Mar;112(3):595-600. doi: 10.1093/bja/aeu025.
No abstract available

Publication types

  • Letter

MeSH terms

  • Europe
  • Fluid Therapy / standards*
  • Humans
  • Hydroxyethyl Starch Derivatives / adverse effects
  • Hydroxyethyl Starch Derivatives / standards*
  • Licensure
  • Pharmaceutical Solutions / standards
  • Pharmacovigilance
  • Plasma Substitutes / adverse effects
  • Plasma Substitutes / standards*
  • Product Recalls and Withdrawals
  • Resuscitation / standards*

Substances

  • Hydroxyethyl Starch Derivatives
  • Pharmaceutical Solutions
  • Plasma Substitutes